(MENAFN- IMARC Group) Setting up an API Manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw ...

Get 30% Off All Global Market Reports With Code ONLINE30 – Stay Ahead Of Trade Shifts, Macroeconomic Trends, And Industry Disruptors” - The Business Research Company LONDON, GREATER LONDON, UNITED ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amide Technologies, a biotech that synthesizes challenging peptides, announced today that it has begun commercializing its novel peptide manufacturing platform. The ...

Investment will double capacity to produce active pharmaceutical ingredients used in therapeutics for a broad range of diseases SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A ...

Technological innovations throughout the past several decades have transformed the pharmaceutical manufacturing process from traditional batch production to ...

AbbVie is investing $195 million in a new API facility in North Chicago, operational by 2027, to enhance US chemical synthesis capabilities. The investment is part of a $10 billion commitment to boost ...

AbbVie (ABBV) announced a $195M investment in its North Chicago, Illinois manufacturing plant to expand domestic active pharmaceutical ingredient production in the U.S. This expansion is part of ...

Hyderabad: Cohance Lifesciences has announced that the United States Food and Drug Administration (USFDA) has completed a ...

Since scoring approval two years ago for its next-generation diabetes treatment Mounjaro (tirzepatide), Eli Lilly has been playing catch up with market leader Novo Nordisk. On Friday, the Indianapolis ...